Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
443.16
+10.09 (2.33%)
At close: Mar 30, 2026, 4:00 PM EDT
445.04
+1.88 (0.42%)
Pre-market: Mar 31, 2026, 8:25 AM EDT
Vertex Pharmaceuticals (VRTX) Revenue by Segment
History
| Date | Trikafta and Kaftrio | Kalydeco | Orkambi | Symdeko and Semkevi |
|---|---|---|---|---|
| Dec 31, 2025 | 10.31B | - | - | - |
| Sep 30, 2025 | 10.46B | - | - | - |
| Jun 30, 2025 | 10.39B | - | - | - |
| Mar 31, 2025 | 10.29B | - | - | - |
| Dec 31, 2024 | 10.19B | - | - | - |
| Sep 30, 2024 | 9.81B | - | - | - |
| Jun 30, 2024 | 9.50B | - | - | - |
| Mar 31, 2024 | 9.29B | - | - | - |
| Dec 31, 2023 | 8.94B | 475.50M | 326.00M | 123.00M |
| Sep 30, 2023 | 8.63B | 499.20M | 392.60M | 129.50M |
| Jun 30, 2023 | 8.37B | 525.80M | 475.80M | 134.30M |
| Mar 31, 2023 | 8.02B | 539.20M | 501.10M | 145.80M |
| Dec 31, 2022 | 7.69B | 553.20M | 510.70M | 180.00M |
| Sep 30, 2022 | 7.36B | 569.30M | 547.30M | 226.10M |
| Jun 30, 2022 | 6.90B | 592.30M | 585.60M | 269.30M |
| Mar 31, 2022 | 6.27B | 636.90M | 685.00M | 360.10M |
| Dec 31, 2021 | 5.70B | 684.20M | 771.60M | 420.40M |
| Sep 30, 2021 | 5.10B | 725.40M | 839.66M | 467.53M |
| Jun 30, 2021 | 4.50B | 756.86M | 881.08M | 542.31M |
| Mar 31, 2021 | 4.16B | 776.62M | 892.06M | 580.54M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.